栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/21 | 2,099 | 2,127 | 2,089 | 2,101 | +3 | +0.1% | 84,100 |
| 2024/11/20 | 2,104 | 2,114 | 2,067 | 2,098 | -6 | -0.3% | 118,900 |
| 2024/11/19 | 2,107 | 2,122 | 2,094 | 2,104 | ±0 | ±0% | 105,800 |
| 2024/11/18 | 2,122 | 2,144 | 2,093 | 2,104 | -68 | -3.1% | 121,100 |
| 2024/11/15 | 2,175 | 2,193 | 2,157 | 2,172 | +3 | +0.1% | 98,400 |
| 2024/11/14 | 2,167 | 2,209 | 2,165 | 2,169 | +2 | +0.1% | 138,800 |
| 2024/11/13 | 2,139 | 2,167 | 2,130 | 2,167 | +27 | +1.3% | 149,900 |
| 2024/11/12 | 2,150 | 2,173 | 2,129 | 2,140 | -8 | -0.4% | 108,500 |
| 2024/11/11 | 2,172 | 2,185 | 2,141 | 2,148 | -42 | -1.9% | 94,800 |
| 2024/11/08 | 2,200 | 2,223 | 2,190 | 2,190 | -18 | -0.8% | 135,600 |
| 2024/11/07 | 2,208 | 2,221 | 2,174 | 2,208 | +1 | ±0% | 150,700 |
| 2024/11/06 | 2,200 | 2,250 | 2,154 | 2,207 | -75 | -3.3% | 204,000 |
| 2024/11/05 | 2,328 | 2,374 | 2,282 | 2,282 | -40 | -1.7% | 162,100 |
| 2024/11/01 | 2,372 | 2,465 | 2,318 | 2,322 | -157 | -6.3% | 257,900 |
| 2024/10/31 | 2,528 | 2,539 | 2,477 | 2,479 | -10 | -0.4% | 141,000 |
| 2024/10/30 | 2,494 | 2,502 | 2,464 | 2,489 | +27 | +1.1% | 407,200 |
| 2024/10/29 | 2,471 | 2,471 | 2,437 | 2,462 | +7 | +0.3% | 68,800 |
| 2024/10/28 | 2,432 | 2,473 | 2,429 | 2,455 | +23 | +0.9% | 62,900 |
| 2024/10/25 | 2,478 | 2,486 | 2,419 | 2,432 | -38 | -1.5% | 111,100 |
| 2024/10/24 | 2,485 | 2,489 | 2,459 | 2,470 | -36 | -1.4% | 89,000 |
| 2024/10/23 | 2,510 | 2,540 | 2,490 | 2,506 | -9 | -0.4% | 68,000 |
| 2024/10/22 | 2,547 | 2,550 | 2,497 | 2,515 | -37 | -1.4% | 75,300 |
| 2024/10/21 | 2,560 | 2,568 | 2,530 | 2,552 | +5 | +0.2% | 103,900 |
| 2024/10/18 | 2,504 | 2,561 | 2,504 | 2,547 | +47 | +1.9% | 125,300 |
| 2024/10/17 | 2,461 | 2,508 | 2,454 | 2,500 | +34 | +1.4% | 119,400 |
| 2024/10/16 | 2,462 | 2,493 | 2,455 | 2,466 | -13 | -0.5% | 78,300 |
| 2024/10/15 | 2,477 | 2,493 | 2,464 | 2,479 | +24 | +1% | 73,500 |
| 2024/10/11 | 2,470 | 2,475 | 2,454 | 2,455 | -2 | -0.1% | 61,700 |
| 2024/10/10 | 2,457 | 2,461 | 2,424 | 2,457 | ±0 | ±0% | 62,600 |
| 2024/10/09 | 2,459 | 2,470 | 2,448 | 2,457 | ±0 | ±0% | 66,400 |
| 2024/10/08 | 2,428 | 2,457 | 2,412 | 2,457 | -3 | -0.1% | 72,600 |
| 2024/10/07 | 2,468 | 2,477 | 2,433 | 2,460 | ±0 | ±0% | 70,400 |
| 2024/10/04 | 2,435 | 2,464 | 2,433 | 2,460 | +42 | +1.7% | 100,300 |
| 2024/10/03 | 2,400 | 2,432 | 2,400 | 2,418 | +52 | +2.2% | 68,700 |
| 2024/10/02 | 2,353 | 2,371 | 2,330 | 2,366 | +10 | +0.4% | 79,900 |
| 2024/10/01 | 2,346 | 2,371 | 2,327 | 2,356 | +32 | +1.4% | 62,900 |
| 2024/09/30 | 2,345 | 2,356 | 2,301 | 2,324 | -71 | -3% | 93,600 |
| 2024/09/27 | 2,410 | 2,439 | 2,355 | 2,395 | -25 | -1% | 138,200 |
| 2024/09/26 | 2,389 | 2,422 | 2,355 | 2,420 | +59 | +2.5% | 166,300 |
| 2024/09/25 | 2,357 | 2,369 | 2,322 | 2,361 | +4 | +0.2% | 79,900 |
| 2024/09/24 | 2,369 | 2,379 | 2,333 | 2,357 | -12 | -0.5% | 81,600 |
| 2024/09/20 | 2,376 | 2,376 | 2,330 | 2,369 | -11 | -0.5% | 101,200 |
| 2024/09/19 | 2,401 | 2,410 | 2,370 | 2,380 | -5 | -0.2% | 57,200 |
| 2024/09/18 | 2,360 | 2,390 | 2,356 | 2,385 | +40 | +1.7% | 58,400 |
| 2024/09/17 | 2,330 | 2,346 | 2,319 | 2,345 | +40 | +1.7% | 50,900 |
| 2024/09/13 | 2,338 | 2,340 | 2,286 | 2,305 | -21 | -0.9% | 77,900 |
| 2024/09/12 | 2,339 | 2,349 | 2,312 | 2,326 | +30 | +1.3% | 55,900 |
| 2024/09/11 | 2,349 | 2,360 | 2,285 | 2,296 | -54 | -2.3% | 51,100 |
| 2024/09/10 | 2,342 | 2,358 | 2,314 | 2,350 | +27 | +1.2% | 34,200 |
| 2024/09/09 | 2,294 | 2,339 | 2,277 | 2,323 | -3 | -0.1% | 45,600 |
1～
50
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 210,100円 | +0.4% | -8.4% | 2.52% | 27.77倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 149,100円 | +3.2% | +4.5% | 3.49% | 17.13倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 69,600円 | -3.7% | -36.7% | 2.87% | 22.92倍 | 1.50倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 96,700円 | - | - | 0.00% | - | 48.69倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| あすかＨＤ | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
